Stryker Corp. (NYSE:SYK) shares hit a new 52-week high on Thursday . The company traded as high as $121.60 and last traded at $121.06, with a volume of 477,120 shares changing hands. The stock had previously closed at $121.09.

A number of research analysts recently weighed in on the stock. SunTrust Banks Inc. increased their price objective on shares of Stryker Corp. from $64.00 to $74.00 and gave the company a “reduce” rating in a research report on Monday, March 28th. Nomura Holdings Inc. assumed coverage on shares of Stryker Corp. in a research report on Thursday, March 17th. They set a “neutral” rating and a $115.00 price objective on the stock. Barclays PLC assumed coverage on shares of Stryker Corp. in a research report on Monday, April 11th. They set an “underweight” rating and a $107.00 price objective on the stock. Piper Jaffray Cos. restated a “buy” rating and set a $120.00 price objective (up previously from $110.00) on shares of Stryker Corp. in a research report on Thursday, April 21st. Finally, Sterne Agee CRT upgraded shares of Stryker Corp. from a “neutral” rating to a “buy” rating and set a $130.00 price objective on the stock in a research report on Wednesday, April 27th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $109.23.

The firm’s 50 day moving average price is $114.57 and its 200 day moving average price is $105.00. The company has a market capitalization of $45.22 billion and a P/E ratio of 28.30.

Stryker Corp. (NYSE:SYK) last issued its quarterly earnings results on Wednesday, April 20th. The medical technology company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.20 by $0.04. During the same period in the previous year, the firm posted $1.11 EPS. The company earned $2.50 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Stryker Corp.’s revenue was up 4.9% compared to the same quarter last year. Equities research analysts forecast that Stryker Corp. will post $5.77 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Thursday, June 30th will be issued a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 1.26%. The ex-dividend date is Tuesday, June 28th.

In other news, CFO Glenn S. Boehnlein sold 2,000 shares of the company’s stock in a transaction on Wednesday, April 27th. The shares were sold at an average price of $109.61, for a total transaction of $219,220.00. Following the completion of the sale, the chief financial officer now owns 2,509 shares of the company’s stock, valued at $275,011.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Ronda E. Stryker sold 12,000 shares of the company’s stock in a transaction on Monday, April 11th. The stock was sold at an average price of $108.46, for a total transaction of $1,301,520.00. Following the sale, the director now directly owns 193,142 shares of the company’s stock, valued at approximately $20,948,181.32. The disclosure for this sale can be found here.

Several large investors have added to or reduced their stakes in the company. Bragg Financial Advisors Inc raised its stake in Stryker Corp. by 0.3% in the fourth quarter. Bragg Financial Advisors Inc now owns 10,900 shares of the medical technology company’s stock worth $1,013,000 after buying an additional 35 shares during the last quarter. Essex Financial Services Inc. raised its stake in Stryker Corp. by 0.3% in the fourth quarter. Essex Financial Services Inc. now owns 11,338 shares of the medical technology company’s stock worth $1,054,000 after buying an additional 30 shares during the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its stake in Stryker Corp. by 3.8% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 11,356 shares of the medical technology company’s stock worth $1,055,000 after buying an additional 420 shares during the last quarter. Brown Advisory Securities LLC raised its stake in Stryker Corp. by 0.8% in the fourth quarter. Brown Advisory Securities LLC now owns 12,761 shares of the medical technology company’s stock worth $1,186,000 after buying an additional 107 shares during the last quarter. Finally, Victory Capital Management Inc. raised its stake in Stryker Corp. by 50.0% in the fourth quarter. Victory Capital Management Inc. now owns 13,405 shares of the medical technology company’s stock worth $1,246,000 after buying an additional 4,467 shares during the last quarter.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.